Skip to main content
. 2011 Mar 23;23(1):78–85. doi: 10.1093/annonc/mdr036

Table 1.

Patients’ characteristics

Feature NSCLC histologic typea
Adenocarcinoma (n = 299), n (%) Squamous carcinoma (n = 164), n (%) P value Total (N = 463), n (%)
Median age (range), years 65 (32–89) 68 (44–90) 0.0353 66 (32–89)
Sex 0.0032
    Male 134 (44.8) 97 (59.1) 232 (50.1)
    Female 165 (55.2) 67 (40.9) 231 (49.9)
Smoking statusb <0.0001
    Never 48 (16.1) 1 (0.6) 49 (10.6)
    Former 133 (44.5) 79 (48.2) 212 (45.8)
    Current 118 (39.5) 84 (51.2) 202 (43.6)
Race 0.87
    Caucasian 273 (91.3) 149 (90.9) 422 (91.1)
    Others 26 (8.7) 15 (9.1) 41 (8.9)
(Neo)adjuvant treatment 0.0159
    No 140 (46.8) 73 (44.5) 213 (46.0)
    Adjuvant 19 (6.4) 21 (12.8) 40 (8.6)
    Neoadjuvant 84 (28.1) 45 (27.4) 129 (27.9)
    Both 26 (8.7) 5 (3.0) 31 (6.7)
    Unknown 30 (10.0) 20 (12.2) 50 (10.8)
T categoryc 0.35
    1 120 (40.1) 58 (35.4) 178 (38.4)
    2 145 (48.5) 85 (51.8) 230 (49.7)
    3 11 (3.7) 11 (6.7) 22 (4.8)
    4 23 (7.7) 10 (6.1) 33 (7.1)
N categoryc 0.0460
    0 214 (71.8) 107 (65.6) 321 (69.6)
    1 42 (13.8) 37 (22.7) 78 (16.9)
    2 43 (14.4) 19 (11.7) 62 (13.4)
    x 1 (0.3) 1 (0.6) 2 (0.4)
Final stagec 0.25
    I 184 (61.5) 93 (56.7) 277 (59.8)
    II 82 (27.4) 58 (35.4) 140 (30.2)
    III 21 (7.0) 10 (6.1) 31 (6.7)
    IV 12 (4.0) 3 (1.8) 15 (3.2)

Never smoker: an adult who has never smoked or who has smoked <100 cigarettes in his or her lifetime; former smoker: an adult who has smoked at least 100 cigarettes in his or her lifetime but who had quit smoking at the time of interview; current smoker: an adult who has smoked 100 cigarettes in his or her lifetime and who currently smokes cigarettes.

a

Values are number of cases unless otherwise indicated.

b

Smoking history was assigned based on the CDC definitions (http://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm, accessed on 29 June 2010).

c

According to the American Joint Committee on Cancer Staging Manual sixth edition.

CDC, Center for Disease Control and Prevention; N, node; NSCLC, non-small-cell lung cancer; T, tumor.